NDC 0832-0044-89 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0832-0044
- Requested NDC
- 0832-0044-89
- Package NDCs from labels
- 0832-0044-09, 0832-0044-10, 0832-0044-89, 0832-0044-01
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Effective date
- 2020-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Upsher-Smith Laboratories, LLC | Upsher-Smith Laboratories, LLC | 2020-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| calcium phosphate, dibasic, dihydrate | INACTIVE INGREDIENT | O7TSZ97GEP | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 1871ddaf-ed2c-c3ce-e063-6394a90a1bee | 2024-12-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Quality Care Products, LLC | a75e4797-6b7f-4366-9105-79d6877adac5 | 2024-12-19 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Quality Care Products, LLC | 6b7c18ef-3a85-4ae3-9135-7ac30a0dde08 | 2024-12-17 | Warnings, Adverse reactions | 864V2Q084H |
| amlodipine besylate | AMLODIPINE BESYLATE | Mylan Pharmaceuticals Inc. | 180ee374-24f2-4b9c-9d54-8815f2b1dc9b | 2024-11-28 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Zydus Lifesciences Limited | cacb3551-c579-41cb-bed6-4b4d8b0644fc | 2024-11-25 | 864V2Q084H | |
| Amlodipine and atorvastatin | AMLODIPINE AND ATORVASTATIN | Mylan Pharmaceuticals Inc. | 4be76756-4114-4d50-a36c-fd410f6c773d | 2024-11-11 | Warnings, Adverse reactions | 864V2Q084H |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 49ec5ac8-a626-4ab2-9799-8a138920201e | 2024-11-06 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | f18148f9-42b2-43dc-9cf8-212d9121dc5f | 2024-11-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | b6eb5283-8e07-47b8-b440-fe72859d8bcc | 2024-10-22 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Zydus Pharmaceuticals USA Inc. | fda0739d-b355-478c-acae-8f773a3ec4b3 | 2024-10-18 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 91e11ca6-05fb-47be-bd40-f8649a35d47d | 2024-10-15 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 3bd019d3-b58c-44ab-9190-606a0af5e9b6 | 2024-10-14 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 699d3ba2-a342-4e3d-b8ad-c14e0df64dfe | 2024-10-09 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | da4e36d3-1ddc-4350-9a00-86975e523f75 | 2024-10-09 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 49d69d27-2a75-4a07-bfb9-24f8af853138 | 2024-10-07 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 03b175fc-d430-490d-b7ac-9f7a2cb1dd8b | 2024-08-31 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | b1151904-5085-49bd-94ec-cb2894f4eb10 | 2024-08-22 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | f16c4254-fb35-408e-9419-e17d684ea5ac | 2024-08-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 204592ba-a68f-452a-9987-1b33b7b6c4d5 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 1b449c22-0181-4a50-94b3-26139b90b978 | 2024-08-07 | Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.